News | April 28, 2010

Experts Compare Notes on SBRT, SRS Techniques

April 28, 2010 - New approaches to image-guidance and motion management are making it possible to successfully target lung, liver and spinal tumors, which are hard to reach even with instruments like stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS).

In a symposium in New York earlier this month, leading clinical experts who have treated more than 3,800 patients with SBRT or SRS, spoke about their own experiences with the technology.

Robert Timmerman, M.D., of the University of Texas Southwestern Medical Center, presented findings from RTOG 0236, a recent multicenter study of SBRT in the treatment of medically inoperable lung cancer patients. At three years post-treatment, the rate of overall survival for these study patients was 56 percent, as compared with historical survival rates of 30 to 50 percent for similar patients treated with conventional radiation. The primary tumor control rate was extremely high at 97.6 percent. Dr. Timmerman noted, "That is more than double the rate of primary tumor control achieved in earlier studies where conventional radiotherapy was used."

Yoshiya Yamada, M.D., Memorial Sloan-Kettering Cancer Center of New York, talked about the role of radiosurgery in managing spine metastases. He said spine radiosurgery is effective for patients who do not have any spinal compression, and he noted the literature consistently shows local control rates of up to 85 percent for these patients. "They often experience near complete pain relief," he said.

By injecting and staining tumors with an iodine-rich oil, Martin Fuss, M.D., professor of radiation medicine at the Oregon Health and Science University in Portland, can more clearly see the image-guidance tools. Dr. Fuss uses intensity-modulated radiation therapy (IMRT) and the RapidArc delivery technique on the Novalis Tx system from Varian and BrainLAB to deliver SBRT treatments for liver tumors. With the enhanced visualization technique, he can concentrate high doses on tumors, while achieving a sharper reduction in dose to tissue around the tumor.

For more information:

Related Content

Videos | Radiation Therapy | August 13, 2018
ITN Editor Dave Fornell takes a tour of some of the innovative new technologies on the expo floor at the 2018 America
Videos | Radiation Therapy | August 13, 2018
A discussion with Mahadevappa Mahesh, MS, Ph.D., FAAPM, FACR, FACMP, FSCCT, professor of radiology and cardiology and
Videos | Proton Therapy | August 10, 2018
A discussion with Matthew Freeman, Ph.D., scientist at Los Alamos National Laboratory, New Mexico.
Videos | Radiomics | August 09, 2018
A discussion with Martin Vallieres, Ph.D., post-doctoral fellow at McGill University, Montreal, Canada.
Videos | AAPM | August 03, 2018
Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke Un...
Videos | Radiation Therapy | August 01, 2018
This is an example of how Cherenkov radiation glow can be collected with image intensifier cameras during radiotherap
Videos | Artificial Intelligence | August 01, 2018
A discussion with Steve Jiang, Ph.D., director of the medical...
Videos | AAPM | August 01, 2018
American Association of Physicists in Medicine (AAPM) President Bruce Thomadsen, M.D., professor of medical physics a
IBA Completes Installation of Two Proteus One Proton Therapy Systems in Japan
News | Proton Therapy | July 30, 2018
IBA (Ion Beam Applications S.A.) announced that they completed the first two installations of the Proteus One proton...
Overlay Init